Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Rivaroxaban
- 30 September 2014
- journal article
- case report
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 23 (10) , e457-e459
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Successful intravenous thrombolysis in acute ischaemic stroke in a patient on rivaroxaban treatmentThrombosis and Haemostasis, 2014
- Dilemma of Indication for Thrombolysis in a Patient with Acute Ischemic Stroke Treated with a Novel Oral AnticoagulantJournal of Stroke and Cerebrovascular Diseases, 2014
- Stroke thrombolysis in patients taking dabigatranInternal Medicine Journal, 2013
- EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary†European Heart Journal, 2013
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial FibrillationCirculation Journal, 2012
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Assays for Measuring Rivaroxaban: Their Suitability and LimitationsTherapeutic Drug Monitoring, 2010
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjectsCurrent Medical Research and Opinion, 2008
- Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitorClinical Pharmacology & Therapeutics, 2005